Home IBB Has A Formidable Challenger In BBP
 

Keywords :   


IBB Has A Formidable Challenger In BBP

2015-05-30 10:41:58| Biotech - Topix.net

A pure biotech ETF, BBP has entered the investment sphere that focuses on the biotechnology cohort with at least one FDA approved product. BBP is a pure biotech play with no holdings in the generic or specialty pharma, life science tools, medical device/diagnostic, or other healthcare companies.

Tags: in formidable challenger

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.10Hurricane Leslie Graphics
05.10Hurricane Leslie Forecast Discussion Number 11
05.10Hurricane Leslie Wind Speed Probabilities Number 11
05.10Hurricane Leslie Public Advisory Number 11
05.10Summary for Hurricane Leslie (AT3/AL132024)
05.10Hurricane Leslie Forecast Advisory Number 11
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 23
More »